AdvanSix Inc. ASIX

Healthcare SIC 2821 - Plastic Materials, Synth Resins & Nonvulcan Elastomers NYSE

On October 1, 2016, Honeywell International Inc. ("Honeywell") completed the separation of AdvanSix. The separation was completed by Honeywell distributing (the "Distribution") all of the then outstanding shares of common stock of AdvanSix on October 1, 2016 (the "Distribution Date") through a dividend in kind of AdvanSix common stock, par value $0.01 per share, to holders of Honeywell common stock as of the close of business on the record date of September 16, 2016 who held their shares through the Distribution Date.

AdvanSix Inc. is an integrated chemistry company that produces essential materials for diverse end markets. Our value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients and chemical intermediates. Our key product lines are as follows:

Last close 17.45 2026-09-04
Market cap $471.2M 2026-06-30 share count
52-week range 14.10 - 26.73

Valuation FY2025 figures against the last close

P/S0.3x
P/E9.7x
P/FCF73.4x
EV/EBITDA
Dividend yield3.6%
Diluted EPS1.80

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.52B$1.52B$1.53B$1.95B$1.68B$1.16B$1.30B$1.51B$1.48B$1.19B
Cost of revenue $1.36B$1.36B$1.37B$1.63B$1.41B$1.02B$1.16B$1.34B$1.25B$1.08B
Gross profit $164.9M$152.9M$165.1M$314.5M$274.1M$133.7M$135.5M$174.5M$227.1M$107.6M
R&D $8.7M$8.8M$9.8M$12.5M$14.0M$11.8M$13.9M$14.8M$12.9M$13.8M
SG&A $104.8M$94.0M$95.5M$87.7M$83.0M$70.9M$75.4M$81.2M$72.7M$53.7M
Interest expense $8.5M$11.3M$7.5M$2.8M$5.0M$7.8M$5.5M$7.5M
Pre-tax income $54.4M$45.6M$69.2M$225.8M$185.1M$55.0M$53.3M$85.8M$144.6M$53.8M
Income tax $5.1M$1.4M$14.6M$53.9M$45.3M$9.0M$12.0M$19.5M$2.1M$19.6M
Net income $49.3M$44.1M$54.6M$171.9M$139.8M$46.1M$41.3M$66.2M$146.7M$34.1M
EPS, basic 1.831.652.006.154.971.641.472.204.811.12
EPS, diluted 1.801.621.955.924.811.641.432.144.721.12
Shares, diluted (wtd. avg.) $27.3M$27.3M$28.0M$29.0M$29.0M$28.2M$28.9M$31.0M$31.1M$30.5M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $19.8M$19.6M$29.8M$31.0M$15.1M$10.6M$7.0M$9.8M$55.4M$14.2M
Inventory $236.5M$212.4M$211.8M$215.5M$149.6M$180.1M$171.7M$137.2M$129.2M$129.0M
Total current assets $440.6M$387.1M$419.8M$440.9M$349.9M$333.5M$290.5M$311.1M$387.8M$282.5M
Property, plant and equipment $811.1M$768.0M$765.5M$755.9M$672.2M$612.6M$575.4M
Goodwill $56.2M$56.2M$56.2M$56.2M$17.6M$15.0M$15.0M$15.0M$15.0M$15.0M
Other intangibles $40.1M$43.1M$46.2M$49.2M$18.0M
Total assets $1.71B$1.59B$1.50B$1.50B$1.31B$1.26B$1.24B$1.03B$1.05B$905.0M
Accounts payable $284.0M$228.8M$259.1M$272.7M$221.2M$190.2M$205.9M$231.7M$227.7M$222.9M
Short-term debt $0$16.9M$0
Total current liabilities $390.0M$357.1M$358.9M$393.5M$309.8M$287.0M$291.7M$284.7M$296.8M$274.0M
Long-term debt $115.0M$135.0M$275.0M$297.0M$0$248.3M$264.8M
Total liabilities $890.9M$820.3M$756.8M$757.2M$710.8M$819.3M$835.1M$614.3M$673.9M$689.6M
Retained earnings $663.0M$631.5M$605.1M$567.5M$411.5M$275.2M$229.2M$187.8M$122.0M-$24.7M
Total equity $815.2M$774.6M$739.2M$738.2M$601.2M$444.1M$400.9M$420.3M$376.3M$215.4M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $122.9M$135.4M$117.5M$273.6M$218.8M$111.8M$120.4M$173.4M$134.6M$113.7M
Depreciation and amortisation $79.7M$76.2M$73.0M$69.4M$65.3M$60.8M$56.8M$53.2M$48.5M$40.3M
Stock-based compensation $6.8M$7.9M$8.3M$10.3M$11.3M$4.9M$8.3M$10.1M$7.7M$1.3M
Capital expenditure $116.4M$133.7M$107.4M$89.4M$56.8M$82.9M$150.3M$109.2M$86.4M$84.0M
Investing cash flow -$122.6M-$142.9M-$110.9M-$189.3M-$67.6M-$84.1M-$153.1M-$112.2M-$93.2M-$86.4M
Financing cash flow -$47.0K-$2.7M-$7.9M-$68.4M-$146.8M-$24.2M$30.0M-$106.8M-$127.0K-$13.2M
Dividends paid $17.2M$17.1M$16.7M$15.1M$3.5M$0$0
Buybacks $1.7M$10.4M$46.2M$33.7M$652.0K$1.1M$62.2M$38.5M$0$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001673985-26-000022.

Others in SIC 2821

TickerCompanyMarket capP/ERevenue growth
DOW DOW INC. $21.22B -7.0%
DD DuPont de Nemours, Inc. $17.77B 1.9%
ALB ALBEMARLE CORP $14.90B -4.4%
EMN EASTMAN CHEMICAL CO $8.14B 17.4x -6.7%
HXL HEXCEL CORP /DE/ $6.96B -0.5%
AVNT AVIENT CORP $3.98B 48.8x 0.6%
ROG ROGERS CORP $2.28B -2.3%
PCT PureCycle Technologies, Inc. $1.28B